USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway. - Wikidata - wikimedia - TriplyDB

USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway.

USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway.

http://www.wikidata.org/entity/Q33787348

about

The protective effects of Resveratrol against radiation-induced intestinal injury.Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway.

P2860

Q41438602-763526D0-4B7F-4DD0-A990-8107717463B4 Q52727759-4FADDE58-CD23-4AB9-89B9-2CAFB7E185E5

P2860

USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway.

http://www.wikidata.org/entity/Q33787348

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

USP22 mediates the multidrug r ...... T1/AKT/MRP1 signaling pathway.

@ast

USP22 mediates the multidrug r ...... T1/AKT/MRP1 signaling pathway.

@en

type

label

USP22 mediates the multidrug r ...... T1/AKT/MRP1 signaling pathway.

@ast

USP22 mediates the multidrug r ...... T1/AKT/MRP1 signaling pathway.

@en

prefLabel

USP22 mediates the multidrug r ...... T1/AKT/MRP1 signaling pathway.

@ast

USP22 mediates the multidrug r ...... T1/AKT/MRP1 signaling pathway.

@en

P1433

Q33787348-EFCC84C9-10CB-4A00-BD74-6E041D7DDBFB

P1476

Q33787348-6D031019-49A0-4B99-BED6-4D38ECD525D9

P2093

Q33787348-0C87EFAE-1DE3-47BE-B9F3-7A3F5E7E1FFB

Q33787348-2C7A8722-EB5E-44BB-85BE-BAF707E235F1

Q33787348-2D9292AA-0203-4B45-89DA-20AA2C885C6F

Q33787348-64F78874-0E1C-40C6-8F6F-870DCE226600

Q33787348-8BF61130-07B3-48CC-B516-73DA7337B2F3

Q33787348-92AEBC69-C88D-4D68-9589-14DDDCC2352B

Q33787348-9423F3AD-6F7C-437B-94B6-D3048FA9647A

Q33787348-9703E53F-C9B3-442F-972D-055CF5124276

Q33787348-A5F36116-F176-4D52-890A-A6C01B29F7AA

Q33787348-F86CB8C8-F329-4A06-AFF3-14B1C8E9B311

P2860

Q33787348-09EF43AF-DBB1-426D-80FF-78B41A888DA0

Q33787348-12A879C8-5AC8-410B-BE8B-49279C4B0BCF

Q33787348-16029862-7CC0-48B1-A2D0-F0448F63E03A

Q33787348-192EBADB-93E2-488E-B43F-1DA5068639A1

Q33787348-1B376A2B-3923-4A7C-822A-44D0DD11E295

Q33787348-2A2F5B59-1BDA-4207-8D30-81695837AEEB

Q33787348-423CD040-A531-4BBD-92C2-5263AFEAF177

Q33787348-43EB42C4-F314-4667-B3DF-1C1241B72C77

Q33787348-4B12B8B4-3903-4729-9B48-B7B58A8401F5

Q33787348-5033DD1F-1F6F-4E15-8B52-91CE5B090A09

P304

Q33787348-5C4187CB-96AF-4091-B336-30C916E00AB1

P31

Q33787348-174C59E9-CFE2-4E46-B3BE-09AABDB1877D

P356

Q33787348-78D4FFD7-E3E1-4FFB-908D-AAF342E331BA

P433

Q33787348-883BEC34-71F9-4EDD-8CA0-EFECCF8345AE

P478

Q33787348-EEA0D1F4-307A-4F08-AC0C-314884863685

P50

Q33787348-3DE8E816-D9AE-4635-9A78-7B1FB38A757C

P577

Q33787348-4CB9E63C-D64F-40E9-98D2-6DD77C308F77

P698

Q33787348-F3AA5541-559C-46E6-9C4F-DFE1010954A8

P921

Q33787348-AD6828D7-8551-418F-90EE-E90D1F7EA4F9

P932

Q33787348-0F9BC373-C606-43EE-AE5F-8126299B6F30

P356

1878-0261.12067

P1433

Molecular Oncology

P1476

USP22 mediates the multidrug r ...... T1/AKT/MRP1 signaling pathway.

@en

P2093

Di Lu

http://www.w3.org/2001/XMLSchema#string

Haiyang Xie

http://www.w3.org/2001/XMLSchema#string

Haojiang Dai

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Jimin Liu

http://www.w3.org/2001/XMLSchema#string

Lin Zhou

http://www.w3.org/2001/XMLSchema#string

Penghong Song

http://www.w3.org/2001/XMLSchema#string

Qiaonan Shan

http://www.w3.org/2001/XMLSchema#string

Shusen Zheng

http://www.w3.org/2001/XMLSchema#string

Xiao Xu

http://www.w3.org/2001/XMLSchema#string

P2860

LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling

The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression

A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex

The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes

Ubiquitin-specific peptidase 22 functions and its involvement in disease

The Warburg effect and drug resistance

Systemic therapies for hepatocellular carcinoma

Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.

P304

682-695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1878-0261.12067

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28417539

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

5467492

http://www.w3.org/2001/XMLSchema#string